Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Phase II study of enzalutamide in androgen receptor positive, recurrent, high- and low-grade serous ovarian cancer

Published:2022-01 Issue:1 Volume:164 Page:12-17
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Manning-Geist Beryl L.,Gordhandas Sushmita B.,Giri Dilip D.,Iasonos Alexia,Zhou Qin,Girshman Jeffrey,O'Cearbhaill Roisin E.,Zamarin Dmitriy,Lichtman Stuart M.,Sabbatini Paul J.,Tew William P.,Li Karen,McDonnell Autumn S.,Aviki Emeline M.,Chi Dennis S.,Aghajanian Carol A.,Grisham Rachel N.

Funder

American Society of Clinical Oncology

National Cancer Institute

Pfizer Inc Boulder

AstraZeneca

Ovarian Cancer Research Fund Alliance

Cycle for Survival

National Institutes of Health

Genentech

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference32 articles.

1. Low-grade serous carcinoma of the ovary or peritoneum;Gershenson;Ann. Oncol.,2016

2. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Ledermann;Ann. Oncol.,2018

3. Ten-year relative survival for epithelial ovarian cancer;Baldwin;Obstet. Gynecol.,2012

4. Characteristics of long-term survivors of epithelial ovarian cancer;Cress;Obstet. Gynecol.,2015

5. An immunohistochemical evaluation of androgen and progesterone receptors in ovarian tumors;Chadha;Hum. Pathol.,1993

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel frontiers in urogenital cancers: from molecular bases to preclinical models to tailor personalized treatments in ovarian and prostate cancer patients;Journal of Experimental & Clinical Cancer Research;2024-05-15

2. In Silico Approach to Molecular Profiling of the Transition from Ovarian Epithelial Cells to Low-Grade Serous Ovarian Tumors for Targeted Therapeutic Insights;Current Issues in Molecular Biology;2024-02-26

3. Steroids in Cancer: Mechanisms, Therapies, and Challenges in Hormone-Driven Malignancies;Interdisciplinary Cancer Research;2024

4. Androgen receptor and its correlation with estrogen and progesterone receptors, aimed for identification of cases for future anti-androgen therapy in endometrial cancers;PLOS ONE;2023-09-19

5. The highs and lows of serous ovarian cancer;Cancer;2023-06-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3